Vaccines-2013 - OMICS Group

November3 rd World Congress onVirologyTheme: “Exploring Novel Approaches in Virology”3 rd World Congress on Virology serves as a meeting ground for scientists in the broad areas of viral infections, preventive andtherapeutic modalities. This conference aims to bring together academic scientists, leading engineers, industry researchers and scholarstudents to exchange and share their experiences, research results about all aspects of virology and viral diseases, and discuss thepractical challenges encountered and the solutions adopted.www.omicsgroup.com/conferences/virology-2013Scientific TracksTrack 1: Modern Approaches in Viral ScienceTrack 1-1 General viral scienceTrack 1-2 Viral genetics and transmissionTrack 1-3 Genomics and proteomics of virusesTrack 1-4 Viral replication mechanismsTrack 2: Viral Breakout Prevention and MeasuresTrack 2-1 New strategies for anti-viral agentsTrack 2-2 Viral threat breakout, prediction, and measuresTrack 2-3 Epidemiology of emerging virusesTrack 2-4 Prevention and measures to curb viral breakoutsTrack 2-5 Viral evolutionTrack 3: Human Viral Diseases Affecting Afro-Asian ContinentsTrack 3-1 Human papilloma virusTrack 3-2 RabiesTrack 3-3 RubellaTrack 3-4 Mumps and measlesTrack 3-5 Japanese encephalitisTrack 3-6 RotavirusTrack 3-7 Hand, foot and mouth diseasesTrack 3-8 Combating viral diseases in Afro-Asian continentsTrack 4: HIV and other Retroviral Diseases Affecting Afro-Asian ContinentsTrack 4-1 Systems biology in HIV, METH and cARTTrack 4-2 HIV diagnosisTrack 4-3 HIV and retroviral transmission and preventionTrack 4-4 Anti-retroviral therapies and associated complicationsTrack 4-5 Psychological and social issues associated with HIVTrack 4-6 Opportunistic diseases in HIVTrack 4-7 Immunology of HIV and retroviral infectionsTrack 4-8 Clinical trials in HIV/AIDSTrack 4-9 Nucleoside analoguesTrack 4-10 HIV vaccines and advancesTrack 4-11 Molecular mechanisms and novel targetsTrack 5: Organ Specific Cancers and Tumour VirologyTrack 5-1 Viral gastroenteritisTrack 5-2 Hepatocellular carcinomasTrack 5-3 HPV associated cervical cancersTrack 5-4 Human herpes virus and cancersTrack 5-5 Simian virus 40Track 5-6 Other cancer associated viral infectionsTrack 6: Respiratory and Vector Borne DiseasesTrack 6-1 Influenza A (H1N1)Track 6-2 Severe acute respiratory syndromeTrack 6-3 Avian flu (H5N1)Track 6-4 Dengue virusTrack 6-5 Hanta virusTrack 6-6 Ebola virusTrack 6-7 West Nile virusTrack 7: Therapeutic Approaches and Targets for Viral InfectionsTrack 7-1 DNA vaccinesTrack 7-2 Interleukin immune therapyTrack 7-3 Antibody therapy against virusesTrack 7-4 Gene therapy for viral infectionsTrack 7-5 Viral vaccinesTrack 7-6 Vaccine allergyTrack 7-7 Antiviral drugs and adjuvantsTrack 7-8 Safety evaluation of viral vaccinesTrack 7-9 Antigen presenting cell-targeted therapyVirology-2013161 st OMICS Group ConferenceDoubleTree by Hilton Baltimore-BWI Airport, MD, USA November 20-22, 2013Track 8: Viral HepatitisTrack 8-1 Hepatitis ATrack 8-2 Hepatitis BTrack 8-3 Hepatitis CTrack 8-4 Hepatitis DTrack 8-5 Hepatitis ETrack 8-6 Epidemiology of hepatitisTrack 8-7 Hepatitis virology and immunologyTrack 9: Viral ImmunologyTrack 9-1 Viral immune evasionTrack 9-2 Receptors and signallingTrack 9-3 Neutralizing antibodiesTrack 9-4 Adjuvants and cell-based immunityTrack 9-5 Prophylactic and therapeutic vaccinesTrack 10: Neurological Infections Associated with VirusesTrack 10-1 Neurological disorders by virusesTrack 10-2 Molecular diagnosis of nervous system virusesTrack 10-3 NeuropathogenesisTrack 10-4 AIDS associated neural diseasesTrack 11: Agriculture and Plant VirologyTrack 11-1 Plant virus epidemiology, ecology, and evolutionTrack 11-2 Viral vector biology and transmissionTrack 11-3 Wheat and rice virusesTrack 11-4 Vegetable virusesTrack 11-5 Tobacco virusTrack 11-6 Grape wine leaf roll diseaseTrack 11-7 Virus resistant plants and disease controlTrack 11-8 Biotechnology in plant viral diseasesTrack 11-9 Viral mediated plant transformationsTrack 12: Animal VirusesTrack 12-1 Zoonoses epidemiologyTrack 12-2 Viroid and prion diseasesTrack 12-3 Functional genomics and proteomics of animal virusesTrack 12-4 Animal vaccines and viral immunologyTrack 13: BacteriophagesTrack 13-1 Impact on bacterial genome evolutionTrack 13-2 Phage therapy and its applicationsTrack 13-3 Clinical trials in phage therapyTrack 13-4 Novel anti-phage mechanisms in bacteriaTrack 14: Recent Advances in Drug DiscoveryTrack 14-1 Bioinformatics in drug discoveryTrack 14-2 Drug-drug interactionsTrack 14-3 Lead targets in drug discoveryTrack 14-4 Antiviral drug resistanceTrack 15: Current Focus on Virology ResearchTrack 15-1 Stem cell therapy for viral infections: Promises and challengesTrack 15-2 New strategies to combat flu virusesTrack 15-3 Strain identification assays and rapid diagnostic testing for viral infectionsTrack 15-4 Clinical virologyTrack 15-5 Viruses and nanotechnologyVirology-2012 ReportThe 2 nd World Conference on Virology was held during August 20-22, 2012 in Las Vegas, USAhighlighting “Innovations and Therapeutic Approaches in Virology”.Virology-2012 was attended by about 200 delegates from across the globe. Eminent speakers gavetheir fruitful contributions at the conference including exhaustive poster presentations by young researchersand veterans. Moreover, workshops on NIH Grantsmanship and High Throughput Screening and AssayDevelopment were organized during the the conference. Simultaneously, Editorial Board Meeting and B2Bsessions between renowned scientists and individuals from business community took place.Page 20